Through its prevention implementation programme, the European Association of Preventive Cardiology (EAPC) developed HeartQoL, a health-related quality of life questionnaire, which is available in more than 30 languages.
The HeartQoL questionnaire is available in the following languages:
Azerbaijani, Bahasa Malaysia, Bulgarian, Chinese [Mandarin], Croatian, Czech, Danish, Dutch, English, Finnish, Flemish, French, German, Greek, Hmong, Hungarian, Icelandic, Italian, Korean, Latvian, Lithuanian, Norwegian, Persian, Polish, Portuguese, Romanian, Russian, Serbian, Spanish, Swedish, Turkish, Ukrainian
Note: If you need the HeartQoL questionnaire in a language not listed above, please indicate this in your application form and the professional translation will be provided together with the HeartQoL pack within one week (upon receipt of payment of the license by the requestor).
The use of HeartQoL is subject to a license. Please see below the set categories and applicable fees. Prices are shown excluding VAT.
- Licenses are valid for a single project
- Content in all 31 languages included in the fee
- No additional fees per additional site/location
- EAPC Accredited centres get free access for audit / quality control purposes
|Category||1-100 Patients||101-250 Patients||251-500 Patients||+500 Patients|
|Validation studies||Free access||Free access||Free access||Free access|
|National Audits (license validity 3 years)||€200||€500||€1,000||€2,000|
|Industry Sponsored Project / Commercial License||€1,000||€2,500||€5,000||€10,000|
Description of each category
- Study aiming to validate HeartQoL in a language not yet validated
- Requesters shall follow the EAPC protocol
- Audit conducted at country level to assess the quality of healthcare, by or in partnership with a National Health organization, national cardiac society
- License validity of 3 years
- Applicable to all other clinical studies / research projects
Industry Sponsored Project / Commercial License:
- Applicable to for-profit companies and Industry-sponsored research
To receive the HeartQoL questionnaire(s) please fill in the request form:
When the request form is approved, you will receive payment instructions and the requested questionnaire(s) will be sent to you by email when the payment is received.
Kindly note, requests are usually processed within 5-10 working days after payment.
Assessing health-related quality of life with HeartQoL - Prof. Neil Oldridge
Testimonials from investigators
"At the University of Hasselt, we use the HeartQoL for research concerning tele-rehabilitation. The questionnaire is quite sensitive to changes in quality of life, and very well adapted to the diverse cardiac population studied" - Prof. Paul Dendale and Dr. Ines Frederix
"Our group has collected data to validate the questionnaire in a broader group of people suffering from cardiac disease. The first paper is published in Atrial Fibrillation. We have further demonstrated that the questionnaire can be used in ICD as well as following valvular surgery. These results are yet to be published. Finally, we have the data to look into the group of patients with infectious endocarditis" - Prof. Ann-Dorthe Zwisler
HeartQoL validation studies
Oldridge N, Höfer S, McGee H, Conroy R, Doyle F, Saner H, et al. The HeartQoL: Part I. Development of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur J Prev Cardiol. 2014;21(1):90-7. (International study, 15 languages)
Oldridge N, Höfer S, McGee H, Conroy R, Doyle F, Saner H, et al. The HeartQoL: Part II. Validation of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur J Prev Cardiol. 2014;21(1):98-106. (International study, 15 languages)
De Smedt D, Clays E, Hofer S, Oldridge N, Kotseva K, Maggioni AP, et al. Validity and reliability of the HeartQoL questionnaire in a large sample of stable coronary patients: The EUROASPIRE IV Study of the European Society of Cardiology. Eur J Prev Cardiol. 2016;23(7):714-21. EUROASPIRE (International study)
Kristensen MS, Zwisler AD, Berg SK, Zangger G, Gronset CN, Risom SS, et al. Validating the HeartQoL questionnaire in patients with atrial fibrillation. Eur J Prev Cardiol. 2016;23(14):1496-503. (Danish)
Lee WL, Chinna K, Bulgiba A, Abdullah KL, Abidin IZ, Hofer S. Test-retest reliability of HeartQoL and its comparability to the MacNew heart disease health-related quality of life questionnaire. Qual Life Res. 2016;25(2):351-7. (English)
Oldridge N, Cho C, Thomas R, Low M, Hofer S. Validation of the English Version of the HeartQoL Health-Related Quality of Life Questionnaire in Patients With Coronary Heart Disease. J Cardiopulm Rehabil Prev. 2018;38:92-9. (English)
Gronset CN, Thygesen LC, Berg SK, Zangger G, Kristensen MS, Sibilitz KL, et al. Measuring HRQoL following heart valve surgery: the HeartQoL questionnaire is a valid and reliable core heart disease instrument. Qual Life Res. 2019;28(5):1245-53. (Danish)
Ranjandish F, Mahmoodi H, Shaghaghi A. Psychometric responsiveness of the health-related quality of life questionnaire (HeartQoL-P) in the Iranian post-myocardial infarction patients. Health Qual Life Outcomes. 2019;17(1):10. (Persian)
Zangger G, Zwisler AD, Kikkenborg Berg S, Kristensen MS, Gronset CN, Uddin J, et al. Psychometric properties of HeartQoL, a core heart disease-specific health-related quality of life questionnaire, in Danish implantable cardioverter defibrillator recipients . Eur J Prev Cardiol. 2018;25(2):142-9. (Danish)
Huber A, Oldridge N, Benzer W, Saner H, Höfer S. Validation of the German HeartQoL: A short health-related quality of life questionnaire for cardiac patients. Qual Life Res. In press. (German)
The HeartQoL questionnaire is valid for use in implantable cardioverter defibrillator recipients.. What does this mean for clinical practice?
Buys R, Goessler KF.
Eur J Prev Cardiol. 2018 Jan;25(2):139-141. doi: 10.1177/2047487317743047.
Cardiac telerehabilitation: A novel cost-efficient care delivery strategy that can induce long-term health benefits.
Frederix I, Solmi F, Piepoli MF, Dendale P.
Eur J Prev Cardiol. 2017 Nov;24(16):1708-1717. doi: 10.1177/2047487317732274.
Self-reported health-related quality of life predicts 5-year mortality and hospital readmissions in patients with ischaemic heart disease.
Hansen TB, Thygesen LC, Zwisler AD, Helmark L, Hoogwegt M, Versteeg H, Höfer S, Oldridge N.
Eur J Prev Cardiol. 2015 Jul;22(7):882-9
For more information, contact us